1. Home
  2. CIM vs CDNA Comparison

CIM vs CDNA Comparison

Compare CIM & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIM
  • CDNA
  • Stock Information
  • Founded
  • CIM 2007
  • CDNA 1998
  • Country
  • CIM United States
  • CDNA United States
  • Employees
  • CIM N/A
  • CDNA N/A
  • Industry
  • CIM Real Estate Investment Trusts
  • CDNA Medical Specialities
  • Sector
  • CIM Real Estate
  • CDNA Health Care
  • Exchange
  • CIM Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • CIM 1.1B
  • CDNA 1.0B
  • IPO Year
  • CIM 2007
  • CDNA 2014
  • Fundamental
  • Price
  • CIM $14.26
  • CDNA $20.51
  • Analyst Decision
  • CIM Buy
  • CDNA Buy
  • Analyst Count
  • CIM 3
  • CDNA 6
  • Target Price
  • CIM $15.50
  • CDNA $30.33
  • AVG Volume (30 Days)
  • CIM 556.5K
  • CDNA 908.5K
  • Earning Date
  • CIM 08-06-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • CIM 10.46%
  • CDNA N/A
  • EPS Growth
  • CIM N/A
  • CDNA N/A
  • EPS
  • CIM 1.52
  • CDNA 1.07
  • Revenue
  • CIM $326,755,000.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • CIM $18.94
  • CDNA $13.31
  • Revenue Next Year
  • CIM $3.05
  • CDNA $15.46
  • P/E Ratio
  • CIM $9.31
  • CDNA $17.91
  • Revenue Growth
  • CIM 11.90
  • CDNA 25.92
  • 52 Week Low
  • CIM $9.85
  • CDNA $14.09
  • 52 Week High
  • CIM $16.89
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • CIM 61.32
  • CDNA 62.23
  • Support Level
  • CIM $14.09
  • CDNA $18.37
  • Resistance Level
  • CIM $14.43
  • CDNA $19.84
  • Average True Range (ATR)
  • CIM 0.25
  • CDNA 0.78
  • MACD
  • CIM -0.00
  • CDNA -0.00
  • Stochastic Oscillator
  • CIM 81.86
  • CDNA 84.56

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: